Midwest biomeds raise $315M in first half of 2011
Midwest biomedical companies have raised $315.1 million in the first half of the year, according to a report from Cleveland-based healthcare advocacy group BioEnterprise, which noted particular substantial investment growth in Ohio-based medical start-ups.
The “BioEnterprise Midwest Health Care Venture Report” noted that of 86 start-up companies in the 11 states which make up the Midwest region, Ohio’s biomedical companies experienced the largest growth, with a 69 percent increase in funding, according to BioEnterprise. Cleveland recorded the second-highest level of healthcare venture capital investments of all the Midwest cities.
“While the number of companies funded remains high and similar to prior years, the total dollars invested is down compared to recent years,” said Baiju R. Shah, president and CEO of BioEnterprise. “This is related to the significant increase in company M&A [mergers & acquisition] activity across the Midwest as growth-stage healthcare firms are increasingly being purchased in strategic transactions rather than pursuing additional financing.”
Minnesota companies garnered $88 million in financing, followed by Ohio, whose companies attracted 80 million during the same period. Among the regions, Minneapolis, Cleveland and Madison, Wis., led the way in financing, according to BioEnterprise.
By sector, biopharmaceutical companies earned the most, at $153 million, followed by medical device companies with $85 million and healthcare software and service companies with $70 million.
Click here to view state-by-state findings.
The “BioEnterprise Midwest Health Care Venture Report” noted that of 86 start-up companies in the 11 states which make up the Midwest region, Ohio’s biomedical companies experienced the largest growth, with a 69 percent increase in funding, according to BioEnterprise. Cleveland recorded the second-highest level of healthcare venture capital investments of all the Midwest cities.
“While the number of companies funded remains high and similar to prior years, the total dollars invested is down compared to recent years,” said Baiju R. Shah, president and CEO of BioEnterprise. “This is related to the significant increase in company M&A [mergers & acquisition] activity across the Midwest as growth-stage healthcare firms are increasingly being purchased in strategic transactions rather than pursuing additional financing.”
Minnesota companies garnered $88 million in financing, followed by Ohio, whose companies attracted 80 million during the same period. Among the regions, Minneapolis, Cleveland and Madison, Wis., led the way in financing, according to BioEnterprise.
By sector, biopharmaceutical companies earned the most, at $153 million, followed by medical device companies with $85 million and healthcare software and service companies with $70 million.
Click here to view state-by-state findings.